Health care interests spent $445 million on federal lobbying in 2007--more than any other sector of the economy--to finish as the top spender for the second consecutive year, according to the Center for Responsive Politics, HealthBeat reports.
In 2007 pharmaceutical and medical products companies rank first with $227 million in spending, while health insurance companies spent the second-most at $138 million. Hospitals and nursing homes spent $91 million, ranking fifth; while health professionals spent $70 million, ranking 15th; and HMOs/health services spent $52 million, ranking 19th.
Among specific organizations or companies, the Pharmaceutical Research and Manufacturers of America spent the third-most at $22.1 million, the American Medical Association spent the fourth-most at $22.1 million and the American Hospital Association was fifth, spending $19.7 million.
According to the CRP, the pharmaceutical industry has spent $1.3 billion on federal lobbying in the last decade, more than any other industry. In addition, the drug industry's reported lobbying increased by 25% from 2006 to 2007.
Lobbying firm, Patton Boggs, whose clients include Bristol-Myers Squibb and Hoffman-La Roche, reported $41.9 million in 2007 revenue—an increase of 20% over 2006--and the most among Washington, D.C.-area firms.
What can we say, except that hopefully a new administration will take some power away from those who blatently put obscene profits before the health care needs of the public.